Rapid Syllable Transition Treatment

This site is a self directed learning package for speech pathologists to learn how to deliver ReST treatment to children with Childhood Apraxia of Speech (CAS) and information for parents and the general community.

ReST treatment has been developed through a series of research studies which have shown that, when delivered as it was designed, ReST treatment can improve the speech accuracy of children and young people with CAS. Details of the research can be found on the research tab.

We would be delighted to hear from speech pathologists who use the site and families whose children have benefited from the therapy.

ReST is a part of the Faculty of Medicine and Health at the University of Sydney. Explore more research within our faculty.


Contact us

Professor Tricia McCabe: tricia.mccabe@sydney.edu.au

Block S
75 East St
Lidcombe NSW 2141

Visitors entry via Gate 2


We gratefully acknowledge the support of the following people and organisations:

  • The original idea for ReST was provided by Prof Don Robin
  • Funding for this website was provided by the Ian Potter Foundation to Tricia McCabe and Cate Madill
  • Pippa Evans and Laura Crocco provided the creative brains for the development of the videos and the website.
  • Sharon Gretz and the team at CASANA have been unfailingly supportive of the development of the site and the treatment research we have conducted at The University of Sydney.
  • Many students, interns, volunteers and clinicians provided support for the research and feedback on drafts of the manual.



Citation and Copyright

McCabe, P., Thomas, D., Murray, E., Crocco, L., & Madill, C. (2017). Rapid Syllable Transition Treatment – ReST The University of Sydney. Retrieved from rest.sydney.edu.au {download date}

This website was created under a Creative Commons Copyright which means you can use, share and modify the content without permission or a licence fee. We strongly encourage you to do so but remember, the closer you stay to the research protocol, the more likely the children you treat will benefit from ReST therapy.

Last updated 22 September 2017